What is the purpose of Pomalidomide 2 mg Capsule?
Pomalidomide 2 mg Capsule is an anti-cancer drug (cancer medicine). Pomalidomide is used to treat AIDS-related Kaposi sarcoma in individuals who have failed to respond to high-dose antiretroviral therapy (HAART). This drug is also used to treat Kaposi sarcoma in non-HIV positive patients (HIV-negative).
When should you start taking Pomalidomide?
- When you’re taking pomalidomide and dexamethasone together, it’s called pomalidomide and dexamethasone.
- Pomalidomide pills are used once a day.
- Dexamethasone is taken in the morning after breakfast.
What are the Pomalidomide 2 mg Capsuleside effects?
- It’s possible that you’ll experience dizziness
- back/bone pain
- muscle discomfort/cramps
- and a loss of appetite.
- Tell your doctor or drug specialist immediately in the event that any of these aftereffects endure or decline. This medicine may
It causes major negative effects on those who take it.
For more details Click Here.
Is Pomalidomide 2 mg Capsule an anti-cancer drug?
Pomalidomide is the generic name for the chemotherapeutic medication Pomalyst®, which is sold under the brand name Pomalyst®. When referring to the generic medicine pomalidomide, health care providers may use the trade name Pomalyst®.
Is it safe to drink alcohol when taking Pomalidomide 2 mg Capsule?
Do not use this drug with any other medications that can make you dizzy or confused. While using this medicine, avoid drinking alcohol.
Pomalidomide 2 mg Capsule belongs to which drug class?
Pomalidomide is a medication that belongs to the immunomodulatory drug family. It works by helping the bone marrow produce normal blood cells while also removing abnormal cells from the marrow.
What is the dosage of pomalidomide?
On an empty stomach, pomalidomide should be taken (at least 2 hours before or 2 hours after a meal). If missed doses are taken within 12 hours of the typical pomalidomide dosing period, they can be given.
What is the effectiveness of Pomalidomide?
Overall, pomalidomide and low-dose dexamethasone resulted in a response rate of 24% versus 4% with high-dose dexamethasone alone. With Pomalidomide plus low-dose dexamethasone, the time without progression of myeloma was 3.6 months on average, compared to 1.8 months with high-dose dexamethasone alone.
If you are looking for another product or brand click here.